ARCHIVES

NCI Plans Trials of Burzynski’s ‘Antineoplaston’; JAMA Report Says No Antitumor Activity In Tests

This article is from The Cancer Letter archive.

Vol. 18 No. 23 | June 5, 1992

Download PDF Visit The Full Archive

Related Articles

House report offers encouragement, but little else, for NCI’s 2015 plan, endorses “biobank” and caBIG.

July 1, 2005

OMB Restrictions On Reprogramming Could Result In Inefficient Last Minute Spending By Institutes

September 13, 1985

Phase II Study of Veliparib Improves PFS by 35 Percent

October 31, 2014

Upton Explains New NCI System: Rants Funded “Across The Board” Strictly By Priority Score

August 25, 1978

Challoner: We Recommended FDA Replace 510(k) Clearance

July 4, 2014

University of Kansas Cancer Center Receives NCI Center Designation

July 13, 2012